Vascular Surgery, Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea.
Department of Surgery, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
World J Surg Oncol. 2024 Apr 25;22(1):112. doi: 10.1186/s12957-024-03390-w.
Carotid body paraganglioma (CBP) is a rare, highly vascularized, and slow-growing neuroendocrine tumor. Surgical resection is the definitive treatment for CBP, however, it remains challenging due to the tumor's proximity to critical blood vessels and cervical cranial nerves. This study aimed to document the characteristics of CBP and examine the clinical outcomes of patients following surgical extirpation of CBP.
This is a single-center retrospective review analyzed patients who underwent CBP extirpation. We examined the patient demographics, preoperative clinical features, tumor characteristics, levels of catecholamines and their metabolites in the serum and urine. Surgeries were performed by one vascular surgeon with follow-ups at 1,3,6 months and yearly thereafter. Logistic regression analysis was conducted to identify risk factors associated with the occurrence of either permanent or temporary cervival cranial nerve palsy (CNP).
From September 2020 to February 2023, this study examined 21 cases of CBP removal surgeries that were carried out in 19 patients. The mean age of the patients was 38.9 ± 10.9 years and the percentage of males was 57.1% (n = 12). The most common preoperative clinical feature was painless neck mass (n = 12; 57.1%). Complete resection was achieved in 20 cases; excluding one case with pathologically proven sclerosing paraganglioma. Vascular procedures were performed in four cases (ECA resection, n = 2; primary repair of ICA tear without carotid shunting, n = 1; and ICA patch angioplasty with carotid shunting, n = 1). Temporary cranial neurologic complications, specifically aspiration and hoarseness occurred in four (19.0%), and three (14.3%) cases, respectively. Hoarseness associated with permanent CNP persisted for more than 6 months in two cases (9.5%). No recurrence or mortality was observed during the follow-up period.
Surgical resection is the primay treatment approach for CBP; however, it poses risks of vascular or cervical CNP. The intraoperative estimated blood loss was the only identified risk factor for CNP.
颈动脉体副神经节瘤(CBP)是一种罕见的、高度血管化的、生长缓慢的神经内分泌肿瘤。手术切除是 CBP 的明确治疗方法,但由于肿瘤靠近关键血管和颈颅神经,手术仍然具有挑战性。本研究旨在记录 CBP 的特征,并检查 CBP 患者手术后的临床结果。
这是一项单中心回顾性研究,分析了接受 CBP 切除术的患者。我们检查了患者的人口统计学特征、术前临床特征、肿瘤特征、血清和尿液中儿茶酚胺及其代谢物的水平。手术由一位血管外科医生进行,术后 1、3、6 个月和此后每年进行随访。采用逻辑回归分析确定与永久性或暂时性颈颅神经麻痹(CNP)发生相关的危险因素。
本研究共纳入了 19 例患者的 21 例 CBP 切除术。患者的平均年龄为 38.9±10.9 岁,男性占 57.1%(n=12)。最常见的术前临床特征是无痛性颈部肿块(n=12;57.1%)。20 例患者达到完全切除,包括 1 例病理证实为硬化性副神经节瘤。4 例患者进行了血管手术(ECA 切除术,n=2;ICA 撕裂未行颈动脉转流的直接修复,n=1;ICA 修补成形术伴颈动脉转流,n=1)。暂时性颅神经并发症,特别是吸入和声音嘶哑分别发生在 4 例(19.0%)和 3 例(14.3%)患者中。2 例(9.5%)患者的永久性 CNP 相关声音嘶哑持续超过 6 个月。在随访期间未观察到复发或死亡。
手术切除是 CBP 的主要治疗方法,但存在血管或颈 CNP 的风险。术中估计失血量是 CNP 的唯一确定危险因素。